Zom Stock
The company is Zomedica Pharmaceuticals. Zom is the ticker reference, company headquarters is in Ann Arbor, Michigan and it was founded by Gerald L. Solensky Jr on January 7, 2013.
Zom Stock Price News
Zomedica was on the the receiving end of a huge amount of press after persuading Netflix’s Tiger King star Carol Baskin to promote the company with a super succesful cameo video appearance.
The nature of the publicity has been such that it appears to have been converted into active trading, with the stock becoming the most actively sold by volume over the past week or so.
The Zom stock price is up 250 so far in 2021 and overall is up 1250 from its 2020 lows back in November.
The Future of Zom Stocks is Bright
While the celebrity promo will have had a novelty impact for sure it is well worth noting that the stock was moving in the right direction even before the celebrity promo and has been in an upward trend since November 2020.
The Track Star IQ (our proprietary search tracking tool) picked up on this rise in interest and shows that over the past week, 63 institutional investors examined the stocks 119 times.
In Zomedica’s latest quarterly report, there was evidence of extensive net losses for the three months ending September 30th, 2020.
The firm appears to have lost approximately 5 million dollars which equates to around one cent per share and for the 9 months, approximately 12.7 million dollars or 4 cents per share.
In a recent letter to its stockholders the conglomerate did announce a major cash injection that took currency funds and equivalents up to 90 billion dollars.
Come March 30th, Zomedica is set to launch a new product called True Forma. This is their proprietary point-of-care diagnostic platform which (according to the press release) is in the process of being brought to the market and commercialized.
Zom Stock Forecast
Zom stock is interesting for a number of reasons.
Clearly it had a particularly poor 2020. This is demonstrated by that year’s losses.
On the other hand, these losses has not prevented the company from successfully raising new capital and now, by all accounts, has a new product set to launch by the end of the first quarter.
Zom Stock Directory [Top 10 Most Helpful Sites]
1. Zomedica Corp. (ZOM) Stock Price, News, Quote & History … Find the latest Zomedica Corp. (ZOM) stock quote, history, news and other vital information to help you with your stock trading and investing.
2. ZOM Stock Forecast, Price & News (Zomedica) | MarketBeat What price target have analysts set for ZOM?
3. Should You Buy ZOM Stock? — StockInvest.us Check if ZOM has a Buy or Sell Evaluation. ZOM Stock Price (NYSE), Score, Forecast, Predictions, and Zomedica Pharmaceuticals Corp News.
4. ZOM — Zomedica Corp Forecast — CNNMoney.com Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Zomedica Corp have a median target of 1.20, with a high estimate of 1.20 and a low .
5. ZOM Stock Forecast, Price Targets and Analysts Predictions Based on 1 analyst offering 12 month price targets for Zomedica Pharmaceuticals in the last 3 months. The average price target is $1.20 with a high forecast of …
6. ZOM — Stock Quotes for Zomedica Corp, AMEX: ZOM Stock … Webull offers Zomedica Corp (ZOM) historical stock prices, in-depth market analysis, AMEX: ZOM real-time stock quote data, in-depth charts, and a fully built ..
7. ZOM Institutional Ownership — Zomedica Pharmaceuticals … (US:ZOM) has 47 institutional owners and shareholders that have filed 13D/G or 13F … Inc., VTSMX — Vanguard Total Stock Market Index Fund Investor Shares. .
8. ZOM Stock — Zomedica Corp. SEC Filings — SEC Report Ticker: ZOM. documents — -0.00084090232849121. Zomedica Corp. is registered with the U.S. Security and Exchange Commission and incorporated in the state of ..
9. ZOM Stock Rating and Data | Zomedica Corp — GuruFocus.com ZOM stock rating and analysis — Zomedica Corp : a summary of key financial strength and profitability metrics.
10. Zomedica Corp Ordinary Shares (ZOM) Quote — XASE … Learn about ZOM (XASE) with our data and independent analysis including price, star rating, valuation, dividends, and financials.
Conclusion
So while the celeb personality blurb and input is fun in terms of highlighting the company and goes someway towards explaining the abrupt ramping up of Zomedica Pharmaceuticals share price, the bottom line is that we see the business as a cash-rich company trading off all-time lows and with a new product about to be launched very soon.
Certainly, Zom stock’s rising star is well worth watching in 2021–22 and beyond.